- Home
- APPS vs PROF Comparison
APPS vs PROF Comparison
Compare APPS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPS
- PROF
- Stock Information
- Founded
- APPS 2007
- PROF N/A
- Country
- APPS United States
- PROF Canada
- Employees
- APPS N/A
- PROF N/A
- Industry
- APPS Multi-Sector Companies
- PROF Medical/Dental Instruments
- Sector
- APPS Miscellaneous
- PROF Health Care
- Exchange
- APPS Nasdaq
- PROF Nasdaq
- Market Cap
- APPS 243.8M
- PROF 201.2M
- IPO Year
- APPS N/A
- PROF N/A
- Fundamental
- Price
- APPS $3.12
- PROF $4.78
- Analyst Decision
- APPS Hold
- PROF Strong Buy
- Analyst Count
- APPS 4
- PROF 1
- Target Price
- APPS $2.38
- PROF $12.00
- AVG Volume (30 Days)
- APPS 3.3M
- PROF 101.3K
- Earning Date
- APPS 05-27-2025
- PROF 05-08-2025
- Dividend Yield
- APPS N/A
- PROF N/A
- EPS Growth
- APPS N/A
- PROF N/A
- EPS
- APPS N/A
- PROF N/A
- Revenue
- APPS $483,577,000.00
- PROF $10,680,000.00
- Revenue This Year
- APPS N/A
- PROF $165.23
- Revenue Next Year
- APPS $6.49
- PROF $96.94
- P/E Ratio
- APPS N/A
- PROF N/A
- Revenue Growth
- APPS N/A
- PROF 48.35
- 52 Week Low
- APPS $1.18
- PROF $3.90
- 52 Week High
- APPS $6.86
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- APPS 53.23
- PROF 28.67
- Support Level
- APPS $3.24
- PROF $4.62
- Resistance Level
- APPS $2.85
- PROF $5.21
- Average True Range (ATR)
- APPS 0.35
- PROF 0.39
- MACD
- APPS 0.06
- PROF -0.02
- Stochastic Oscillator
- APPS 94.39
- PROF 41.07
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.